Cargando…
A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity
BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common pathological type of glomerular disease. Kidney biopsy, the gold standard for IgAN diagnosis, has not been routinely applied in hospitals worldwide due to its invasion nature. Thus, we aim to establish a non-invasive diagnostic model...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416104/ https://www.ncbi.nlm.nih.gov/pubmed/30855344 http://dx.doi.org/10.1097/CM9.0000000000000121 |
_version_ | 1783403283118817280 |
---|---|
author | Han, Qiu-Xia Wang, Yong Zhu, Han-Yu Zhang, Dong Gao, Jing Liu, Zhang-Suo Cai, Guang-Yan Chen, Xiang-Mei |
author_facet | Han, Qiu-Xia Wang, Yong Zhu, Han-Yu Zhang, Dong Gao, Jing Liu, Zhang-Suo Cai, Guang-Yan Chen, Xiang-Mei |
author_sort | Han, Qiu-Xia |
collection | PubMed |
description | BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common pathological type of glomerular disease. Kidney biopsy, the gold standard for IgAN diagnosis, has not been routinely applied in hospitals worldwide due to its invasion nature. Thus, we aim to establish a non-invasive diagnostic model and determine markers to evaluate disease severity by analyzing the serological parameters and pathological stages of patients with IgAN. METHODS: A total of 272 biopsy-diagnosed IgAN inpatients and 518 non-IgA nephropathy inpatients from the Department of Nephrology of Chinese People's Liberation Army General Hospital were recruited for this study. Routine blood examination, blood coagulation testing, immunoglobulin-complement testing, and clinical biochemistry testing were conducted and pathological stages were analyzed according to Lee grading system. The serological parameters and pathological stages were analyzed. The receiver operating characteristic (ROC) analysis was performed to estimate the diagnostic value of the clinical factors. Logistic regression was used to establish the diagnostic model. RESULTS: There were 15 significantly different serological parameters between the IgAN and non-IgAN groups (all P < 0.05). The ROC analysis was performed to measure the diagnostic value for IgAN of these parameters and the results showed that the area under the ROC curve (AUC) of total protein (TP), total cholesterol (TC), fibrinogen (FIB), D-dimer (D2), immunoglobulin A (IgA), and immunoglobulin G (IgG) were more than 0.70. The AUC of the “TC + FIB + D2 + IgA + age” combination was 0.86, with a sensitivity of 85.98% and a specificity of 73.85%. Pathological grades of I, II, III, IV, and V accounted for 2.21%, 17.65%, 62.50%, 11.76%, and 5.88%, respectively, with grade III being the most prevalent. The levels of urea nitrogen (UN) (13.57 ± 5.95 vs. 6.06 ± 3.63, 5.92 ± 2.97, 5.41 ± 1.73, and 8.41 ± 3.72 mmol/L, respectively) and creatinine (Cr) (292.19 ± 162.21 vs. 80.42 ± 24.75, 103.79 ± 72.72, 96.41 ± 33.79, and 163.04 ± 47.51 μmol/L, respectively) were significantly higher in grade V than in the other grades, and the levels of TP (64.45 ± 7.56, 67.16 ± 6.94, 63.22 ± 8.56, and 61.41 ± 10.86 vs. 37.47 ± 5.6 mg/d, respectively), direct bilirubin (DB) (2.34 ± 1.23, 2.58 ± 1.40, 1.91 ± 0.97, and 1.81 ± 1.44 vs. 0.74 ± 0.57 μmol/L, respectively), and IgA (310.35 ± 103.78, 318.48 ± 107.54, 292.58 ± 81.85, and 323.29 ± 181.67 vs. 227.17 ± 68.12 g/L, respectively) were significantly increased in grades II–V compared with grade I (all P < 0.05). CONCLUSIONS: The established diagnostic model that combined multiple factors (TC, FIB, D2, IgA, and age) might be used for IgAN non-invasive diagnosis. TP, DB, IgA, Cr, and UN have the potential to be used to evaluate IgAN disease severity. |
format | Online Article Text |
id | pubmed-6416104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-64161042019-03-19 A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity Han, Qiu-Xia Wang, Yong Zhu, Han-Yu Zhang, Dong Gao, Jing Liu, Zhang-Suo Cai, Guang-Yan Chen, Xiang-Mei Chin Med J (Engl) Original Articles BACKGROUND: Immunoglobulin A nephropathy (IgAN) is the most common pathological type of glomerular disease. Kidney biopsy, the gold standard for IgAN diagnosis, has not been routinely applied in hospitals worldwide due to its invasion nature. Thus, we aim to establish a non-invasive diagnostic model and determine markers to evaluate disease severity by analyzing the serological parameters and pathological stages of patients with IgAN. METHODS: A total of 272 biopsy-diagnosed IgAN inpatients and 518 non-IgA nephropathy inpatients from the Department of Nephrology of Chinese People's Liberation Army General Hospital were recruited for this study. Routine blood examination, blood coagulation testing, immunoglobulin-complement testing, and clinical biochemistry testing were conducted and pathological stages were analyzed according to Lee grading system. The serological parameters and pathological stages were analyzed. The receiver operating characteristic (ROC) analysis was performed to estimate the diagnostic value of the clinical factors. Logistic regression was used to establish the diagnostic model. RESULTS: There were 15 significantly different serological parameters between the IgAN and non-IgAN groups (all P < 0.05). The ROC analysis was performed to measure the diagnostic value for IgAN of these parameters and the results showed that the area under the ROC curve (AUC) of total protein (TP), total cholesterol (TC), fibrinogen (FIB), D-dimer (D2), immunoglobulin A (IgA), and immunoglobulin G (IgG) were more than 0.70. The AUC of the “TC + FIB + D2 + IgA + age” combination was 0.86, with a sensitivity of 85.98% and a specificity of 73.85%. Pathological grades of I, II, III, IV, and V accounted for 2.21%, 17.65%, 62.50%, 11.76%, and 5.88%, respectively, with grade III being the most prevalent. The levels of urea nitrogen (UN) (13.57 ± 5.95 vs. 6.06 ± 3.63, 5.92 ± 2.97, 5.41 ± 1.73, and 8.41 ± 3.72 mmol/L, respectively) and creatinine (Cr) (292.19 ± 162.21 vs. 80.42 ± 24.75, 103.79 ± 72.72, 96.41 ± 33.79, and 163.04 ± 47.51 μmol/L, respectively) were significantly higher in grade V than in the other grades, and the levels of TP (64.45 ± 7.56, 67.16 ± 6.94, 63.22 ± 8.56, and 61.41 ± 10.86 vs. 37.47 ± 5.6 mg/d, respectively), direct bilirubin (DB) (2.34 ± 1.23, 2.58 ± 1.40, 1.91 ± 0.97, and 1.81 ± 1.44 vs. 0.74 ± 0.57 μmol/L, respectively), and IgA (310.35 ± 103.78, 318.48 ± 107.54, 292.58 ± 81.85, and 323.29 ± 181.67 vs. 227.17 ± 68.12 g/L, respectively) were significantly increased in grades II–V compared with grade I (all P < 0.05). CONCLUSIONS: The established diagnostic model that combined multiple factors (TC, FIB, D2, IgA, and age) might be used for IgAN non-invasive diagnosis. TP, DB, IgA, Cr, and UN have the potential to be used to evaluate IgAN disease severity. Wolters Kluwer Health 2019-03-20 2019-03-20 /pmc/articles/PMC6416104/ /pubmed/30855344 http://dx.doi.org/10.1097/CM9.0000000000000121 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 |
spellingShingle | Original Articles Han, Qiu-Xia Wang, Yong Zhu, Han-Yu Zhang, Dong Gao, Jing Liu, Zhang-Suo Cai, Guang-Yan Chen, Xiang-Mei A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity |
title | A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity |
title_full | A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity |
title_fullStr | A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity |
title_full_unstemmed | A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity |
title_short | A non-invasive diagnostic model of immunoglobulin A nephropathy and serological markers for evaluating disease severity |
title_sort | non-invasive diagnostic model of immunoglobulin a nephropathy and serological markers for evaluating disease severity |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416104/ https://www.ncbi.nlm.nih.gov/pubmed/30855344 http://dx.doi.org/10.1097/CM9.0000000000000121 |
work_keys_str_mv | AT hanqiuxia anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT wangyong anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT zhuhanyu anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT zhangdong anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT gaojing anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT liuzhangsuo anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT caiguangyan anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT chenxiangmei anoninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT hanqiuxia noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT wangyong noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT zhuhanyu noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT zhangdong noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT gaojing noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT liuzhangsuo noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT caiguangyan noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity AT chenxiangmei noninvasivediagnosticmodelofimmunoglobulinanephropathyandserologicalmarkersforevaluatingdiseaseseverity |